2011
DOI: 10.1111/j.1365-2559.2011.03977.x
|View full text |Cite
|
Sign up to set email alerts
|

New evidence for a critical role of elastin in calcification of native heart valves: immunohistochemical and ultrastructural study with literature review

Abstract: Our results demonstrate the direct involvement of MMP-12 in native aortic valve stenosis. MMP-mediated degradation of elastic fibres might contribute actively to valve mineralization by inducing calcium deposition onto fragmented elastin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
42
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 65 publications
(47 citation statements)
references
References 58 publications
(93 reference statements)
2
42
0
Order By: Relevance
“…Previous studies have shown that mechanisms of AVD recapitulate developmental programs, suggesting that the dysregulation of specific structural proteins and signaling pathways incite disease and contribute to faulty homeostasis over time and ultimately valve dysfunction later in life (Markwald et al, 2010; Hinton and Yutzey, 2011; Mahler and Butcher, 2011). Elastic fiber fragments, or degradation products, might have pro-angiogenic, pro-proliferative, pro-calcific or pro-inflammatory properties (Perrotta et al, 2011; Pivetta et al, 2014; Parks and Mecham, 2011), in addition to well-described increases in elastase activity (Robinet et al, 2005), suggesting that different elastic fiber fragments have different maladaptive effects. In this context, Emilin1 -deficiency-related EFF results in aberrant angiogenesis and fibrosis, but not calcification.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have shown that mechanisms of AVD recapitulate developmental programs, suggesting that the dysregulation of specific structural proteins and signaling pathways incite disease and contribute to faulty homeostasis over time and ultimately valve dysfunction later in life (Markwald et al, 2010; Hinton and Yutzey, 2011; Mahler and Butcher, 2011). Elastic fiber fragments, or degradation products, might have pro-angiogenic, pro-proliferative, pro-calcific or pro-inflammatory properties (Perrotta et al, 2011; Pivetta et al, 2014; Parks and Mecham, 2011), in addition to well-described increases in elastase activity (Robinet et al, 2005), suggesting that different elastic fiber fragments have different maladaptive effects. In this context, Emilin1 -deficiency-related EFF results in aberrant angiogenesis and fibrosis, but not calcification.…”
Section: Discussionmentioning
confidence: 99%
“…Accordingly, it had been shown that ECM structural damage impacts valve durability, leading to allograft degeneration (Schenke-Layland et al, 2009; Lisy et al, 2010). Moreover, it was demonstrated that macrophage metalloproteinase (MMP12)-mediated degradation of elastic fibers contributes to valve mineralization by inducing calcium deposition onto fragmented elastin, which was identified as the initial site of calcification (Perrotta et al, 2011). Emerging evidence suggests that elastin degradation contributes to arterial and aortic valve calcification via the action of macrophage-derived cathepsin S, a highly potent elastase (Aikawa et al, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…Emerging evidence suggests that elastin degradation contributes to arterial and aortic valve calcification via the action of macrophage-derived cathepsin S, a highly potent elastase (Aikawa et al, 2009). Mutations in ELN and microfibril-associated protein genes are known to cause a variety of congenital cardiovascular diseases (Table 1), including Marfan, Beals and Williams-Beuren syndromes, as well as cutis laxa (Curran et al, 1993; Ewart et al, 1993; Loeys et al, 1993; Putnam et al, 1995; Ramirez, 1996; Tassabehji et al, 1998; Loeys et al, 2002; Aikawa et al, 2009; Perrotta et al, 2011). …”
Section: Discussionmentioning
confidence: 99%
“…Calcific aortic stenosis (CAS) is the most common form of valve disease in the Western world, strongly related to aging, and histologically characterized by diffuse fibrous thickening, distortion of the valve leaflet and extensive calcification [1]. Although first described by Monckeberg nearly a century ago, to date little is known regarding the molecular and cellular events that control the stenosing process with only a few reports dealing with the structural appearance of mineralized collagen in the calcifying tissue of native aortic valve [2][3][4].…”
mentioning
confidence: 99%